Ledipasvir — Hepatitis C Treatment

Ledipasvir is a direct-acting antiviral agent used to treat chronic hepatitis C infections. It targets the NS5A protein, a key component the virus needs to replicate inside liver cells. When combined with Sofosbuvir, it forms one of the most effective oral treatments for HCV, achieving cure rates above 95%. Ledipasvir is generally well-tolerated and helps restore liver health by eliminating the virus from the bloodstream in just a few weeks of therapy.